Valuation: Zoetis Inc.

Market Cap 31.59B 27.69B 25.65B 23.61B 44.53B 3,042B 45.06B 306B 120B 1,491B 119B 116B 5,148B P/E 2026 *
11.8x
P/E 2027 * 10.8x
Enterprise Value 38.31B 33.58B 31.12B 28.64B 54.01B 3,690B 54.66B 371B 145B 1,808B 144B 141B 6,244B EV / Sales 2026 *
3.93x
EV / Sales 2027 * 3.69x
Free-Float
83.58%
Yield 2026 *
2.85%
Yield 2027 * 3.07%
1 day-1.38%
1 week-0.64%
Current month+3.69%
1 month-3.09%
3 months-35.13%
6 months-38.94%
Current year-39.27%
1 week 65.16
Extreme 65.16
67.72
1 month 62.7
Extreme 62.7
70.02
Current year 62.7
Extreme 62.7
114.98
1 year 62.7
Extreme 62.7
137.14
3 years 62.7
Extreme 62.7
185
5 years 62.7
Extreme 62.7
221
10 years 62.7
Extreme 62.7
221
Manager TitleAgeSince
Chief Executive Officer 54 2019-12-31
Director of Finance/CFO 54 2021-05-31
Chief Tech/Sci/R&D Officer 49 2025-12-31
Director TitleAgeSince
Director/Board Member 68 2012-06-30
Director/Board Member 68 2012-12-31
Chairman 73 2013-06-25
Change 5-day change 1-year change 3-year change Capi.($)
-1.45%-0.64% - - 31.59B
+1.14%+0.43%+71.80%+112.86% 12.73B
+2.51%+2.64%-19.43%0.00% 3.62B
+2.34%+9.38%-1.82%+30.11% 3.27B
+0.74%+7.94%-3.19%+25.74% 1.84B
-1.82%-5.12%+25.56%+10.24% 1.86B
+0.59%+0.25%+15.72%+124.30% 1.37B
-1.79%-0.69%-25.61%-14.32% 1.09B
0.00%+2.72%-18.84%-48.27% 968M
-0.14%-1.24%-7.60%-20.69% 952M
Average +0.20%+0.51%+4.07%+24.44% 3.08B
Weighted average by Cap. -0.29%+0.63%+30.58%+61.01%

Financials

2026 *2027 *
Net sales 9.75B 8.55B 7.92B 7.29B 13.75B 939B 13.92B 94.55B 37B 460B 36.62B 35.83B 1,590B 10.15B 8.9B 8.24B 7.59B 14.31B 978B 14.48B 98.39B 38.5B 479B 38.1B 37.28B 1,654B
Net income 2.7B 2.37B 2.19B 2.02B 3.81B 260B 3.85B 26.17B 10.24B 127B 10.14B 9.92B 440B 2.93B 2.57B 2.38B 2.19B 4.14B 283B 4.19B 28.44B 11.13B 139B 11.02B 10.78B 478B
Net Debt 6.73B 5.9B 5.46B 5.03B 9.48B 648B 9.6B 65.19B 25.51B 317B 25.25B 24.7B 1,096B 5.82B 5.11B 4.73B 4.35B 8.21B 561B 8.31B 56.46B 22.09B 275B 21.86B 21.39B 949B
Logo Zoetis Inc.
Zoetis Inc. specializes in developing, manufacturing and marketing of animal health products. Net sales break down by activity as follows: - companion animal (67.8%): cats and dogs (95.5% of net sales) and horses (4.5%); - livestock (31.3%): cattle (52.8% of sales), poultry (18.2%), swine (17.8%), fish (8.4%) and other (2.8%); - other (0.9%). Net sales break down by family of products into parasiticides (23.3%), vaccines (19.7%), dermatological products (17.9%), anti-infectives (11.9%), pain relievers (9.2%), diagnostic products (4.2%), medicated feed additives (3.2%) and other (10.6%). At the end of 2024, the group has 22 production sites worldwide. The United States accounts for 54.8% of net sales.
Employees
14,500
Date Price Change Volume
26-07-22 65.16 -1.45% 1,259
26-07-21 €66.12 -0.48% 722
26-07-20 €66.44 -1.16% 1,719
26-07-17 €67.22 -0.21% 350
26-07-16 €67.36 +2.71% 986
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
75.35USD
Average target price
113.82USD
Spread / Average Target
+51.06%

Quarterly revenue - Rate of surprise